Sign Up Today and Learn More About Accolade Stock
Invest in or calculate the value of your shares in Accolade or other pre-IPO companies through EquityZen's platform.
About Accolade Stock
Founded
2007
Headquarters
Plymouth Meeting, PA, US
Total Funding
237M
Industries
Software, Artificial Intelligence, Data and Analytics
Accolade is a health, wellness, and fitness company that features personalized health and benefits solutions that help to improve the experience, outcomes, and cost of healthcare for employers. It specializes in healthcare process improvement, healthcare savings, employee engagement, and personalized advocacy. The company was founded in 2007 and headquartered in Pennsylvania, United States.
Accolade Press Mentions
Stay in the know about the latest news on Accolade
Accolade COVID Response Care Delivers the U.S.' First Comprehensive Clinical Solution for Reopening Workplaces with Care and Confidence
Daily Records • May 27, 2020
Vivante Health Joins Accolade Trusted Supplier Program
PR Newswire • May 07, 2020
Insurance giant Humana invests $20M in healthcare tech company Accolade
geekwire • Oct 10, 2019
Accolade uses acquisition of MD Insider to launch doctor-picking concierge
geekwire • Aug 01, 2019
Accolade and Humana Integrate their Solutions to Optimize the Consumer Experience and Control Healthcare Spend for Self-funded Employers
businesswire • Mar 15, 2019
Investors in Accolade
Discover investors in Accolade stock and explore their portfolio companies
Accolade Management
Leadership team at Accolade
Chief Executive Officer
Rajeev Singh
Chief Financial Officer
Steve Barnes
Join now and verify your accreditation status to gain access to:
- Accolade Current Valuation
- Accolade Stock Price
- Accolade Management
- Available deals in Accolade and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Accolade Cap Table and Funding History by Share Class and Liquidity Preferences
- Accolade Revenue and Financials
- Accolade Highlights
- Accolade Business Model
- Accolade Risk Factors
- Accolade Research Report from SACRA Research
Trading Accolade Stock
How to invest in Accolade stock?
Accredited investors can buy pre-IPO stock in companies like Accolade through EquityZen funds. These investments are made available by existing Accolade shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Accolade stock?
Shareholders can sell their Accolade stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."